-
I655139-1mlI-BET282 is a pan-inhibitor of all eight BET bromodomains , and selectivity over other representative bromodomain-containing proteins. I-BET282 shows pIC 50 s ranging 6.4-7.7 for BRD2 (BD1/BD2), BRD2 (BD1/BD), BRD3 (BD1/BD), and BRD4 (BD1/BD).In
-
I648937-10mgI-BET567 is a potent and orally active inhibitor of pan-BET candidate with pIC 50 s of 6.9 and 7.2 for BRD4 BD1 and BD2 , respectively. I-BET567 has been demonstrated efficacy in mouse models of oncology and inflammationIn VitroI-BET567 (compound
-
I648937-5mgI-BET567 is a potent and orally active inhibitor of pan-BET candidate with pIC 50 s of 6.9 and 7.2 for BRD4 BD1 and BD2 , respectively. I-BET567 has been demonstrated efficacy in mouse models of oncology and inflammationIn VitroI-BET567 (compound
-
I648165-100mgIACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia
-
I648165-10mgIACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia
-
I648165-25mgIACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia
-
I648165-50mgIACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia
-
I648165-5mgIACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia
-
I655321-1mlIACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia
-
I650212-10mgIACS-8968 (IDO/TDO Inhibitor) is a dual IDO and TDO inhibitor, with pIC 50 s of 6.43 for IDO and <:5 for TDO, respectively.Form:SolidIC50&: Target:pIC50: 6.43 (IDO), <:5 (TDO).
-
I650212-1mgIACS-8968 (IDO/TDO Inhibitor) is a dual IDO and TDO inhibitor, with pIC 50 s of 6.43 for IDO and <:5 for TDO, respectively.Form:SolidIC50&: Target:pIC50: 6.43 (IDO), <:5 (TDO).
-
I650212-5mgIACS-8968 (IDO/TDO Inhibitor) is a dual IDO and TDO inhibitor, with pIC 50 s of 6.43 for IDO and <:5 for TDO, respectively.Form:SolidIC50&: Target:pIC50: 6.43 (IDO), <:5 (TDO).